Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01825096 · ClinicalTrials.gov registry record
Simultaneous FMRI and NIRS to Estimate Brain Cerebral Metabolism
A clinical trial, sponsored by Mclean Hospital.
- Completed
- Registry status
- 1
- Enrollment target
NCT01825096 is a clinical trial that has completed, run by Mclean Hospital. The registered enrollment target is 1 participants.
The verdict
NCT01825096 has completed, sponsored by Mclean Hospital.
- COMPLETED
- Registry status
- 1 participants
- Enrollment target
Study Summary
The principal advantages of functional magnetic resonance imaging (fMRI) with blood-oxygenation- level-dependent (BOLD) contrast for studying brain function are: non-invasiveness, ubiquitous availability, relatively high spatiotemporal resolution, and the ability to map function over the entire brain. Thus, BOLD fMRI is the most widely applied technology to study healthy brain function and pathophysiology associated with disease. In studies of drug abuse and psychiatric illness though, normal assumptions mapping BOLD signals to neurometabolism may be violated. Generally, these effects are ignored, resulting in large study-to-study variability. Quantitative fMRI (qfMRI) measures metabolism directly and is more suitable for studies of drug abuse and psychiatric illness. However, qfMRI is too complex for routine use. Cerebral metabolism during brain activation during visual stimulation measured with a new fMRI approach that is simple enough for clinical applications will be compared to CMRO2 activation measured using standard qfMRI.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2012-03 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01825096
The ClinicalTrials.gov registry entry for NCT01825096 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mclean Hospital, which has 140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01825096 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01825096 about?
NCT01825096 is a clinical study titled "Simultaneous FMRI and NIRS to Estimate Brain Cerebral Metabolism". The principal advantages of functional magnetic resonance imaging (fMRI) with blood-oxygenation- level-dependent (BOLD) contrast for studying brain function are: non-invasiveness, ubiquitous availability, relatively high spatiotemporal resolution, and the ability to map function over the entire brai...
What is the current status of trial NCT01825096?
This trial is currently completed. The enrollment target is 1 participants. The study started on 2012-03. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT01825096?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.